This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Insitro, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Panagiotis Dimitrios Stanitsas: Innovator in Disease Modeling through Microscopy
Introduction
Panagiotis Dimitrios Stanitsas is a notable inventor based in Palo Alto, California. He has made significant contributions to the field of microscopy and machine learning, particularly in the context of disease modeling. His innovative work has the potential to enhance the understanding and treatment of various diseases.
Latest Patents
Stanitsas holds a patent for "Microscopy image analyses for disease modeling." This patent encompasses systems and non-transitory computer-readable media designed for analyzing microscopy images. The technology aims to develop machine learning models that can effectively distinguish between healthy and diseased samples based on microscopy images captured from cells exhibiting different exposure response phenotypes (ERPs). This advancement in microscopy image analysis is crucial for improving disease modeling techniques.
Career Highlights
Currently, Panagiotis Stanitsas is employed at Insitro, Inc., a company focused on leveraging machine learning and data science to accelerate drug discovery and development. His role at Insitro allows him to apply his expertise in microscopy and machine learning to real-world challenges in healthcare.
Collaborations
Throughout his career, Stanitsas has collaborated with esteemed colleagues, including Daphne Koller and Ajamete Kaykas. These collaborations have further enriched his work and contributed to advancements in the field of disease modeling.
Conclusion
Panagiotis Dimitrios Stanitsas is a pioneering inventor whose work in microscopy and machine learning is paving the way for innovative approaches to disease modeling. His contributions are significant in the ongoing quest to improve healthcare outcomes through technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile